Allergic bronchopulmonary fungal disease is characterised by asthma, eosinophilia, infiltrates on the chest radiograph, raised IgE levels, precipitating antibodies, and immediate skin reactivity to the causal fungus.' Its management differs from that of simple asthma and frequently requires prolonged use of corticosteroids to minimise development of proximal bronchiectasis.
Aspergillus species are the most common fungi implicated in allergic bronchopulmonary fungal disease, but more recently other fungi, including Curvularia, Drechslera,2 Helminthosporium, Candida albicans, Stemphylium, Torulopsis, and Bipolaris' have been reported. Mixed her only medication was inhaled salbutamol and the oral contraceptive pill.
On admission she had a cough producing green-brown sputum with obvious plugs. Her asthma appeared stable, she was afebrile, and she had bronchial breathing over the right upper zone. Chest radiographs four months earlier showed a left upper lobe infiltrate extending from the hilum. Subsequent radiographs showed changing recurrent shadows and when she was admitted there was considerable right hilar shadowing (fig 1) . The forced expiratory volume in one second (FEV,) and forced vital capacity (FVC) were 2-2 and 2 9 litres, (predicted 3 0 and 3-6 1). A full blood count showed eosinophilia (1-7 x 109 cells/l; normal < 0-4 x 109) and the total IgE was greater than 4000 IU (normal < 300 IU). Skin prick testing was performed with reagents from the Hollister Stier Laboratories, Washington. In addition a freeze dried cytoplasmic extract of P boydii was prepared by the method described by Mackenzie et al5 and reconstituted to 20 mg of freeze dried extract/ml of distilled water for skin prick testing. The patient had skin weal responses as follows: Aspergillusfumigatus (6 mm), A terreus (7 mm), A niger (3 mm), A nidulans (3 mm), Alternaria sp (8 mm) , Helminthosporium (9 mm), Curvularia sp (12 mm), Stemphylium botryosum (10 mm), and P boydii (7 mm). The skin reaction to 1 0 mg/ml of histamine was 6 mm. Precipitating antibodies were detected by the double immunodiffusion technique5 with cytoplasmic extracts of the fungi, the patient's serum, and a control solution of hyperimmune rabbit antiserum. Antibodies were detected in the patient's serum on two occasions one month apart. Initial assessment showed the presence of P boydii (two bands), A fumigatus (three bands), and A flavus (one band) and on the Lake, Tribe, McAleer, Froudist, Thompson Aspergillus species did not cross react with P boydii in immunodiffusion studies using hyperimmune rabbit antisera.
At bronchoscopy plugs of sputum were aspirated from the right upper lobe. A bronchoalveolar lavage specimen showed a high neutrophil (760/1) and eosinophil count (12.50,o) (normal: neutrophils < 2%, eosinophils < 0-5°h). Four bronchoscopy specimens and one sputum specimen were cultured at 25°C and 37°C on five media. All specimens showed large amounts of septate branching mycelia and grew multiple colonies of P boydii, which were floccose, smoky grey on the surface, and blackish on the reverse. The fungus grew initially in the anamorph state, Scedosporium apiospermum (fig 2) , but was later induced to produce ascomas on water agar. Occasional colonies of A terreus were also grown. Disease due to P boydii has been infrequently reported and this may reflect problems with its identification. P boydii resembles other fungal species in tissue specimens and may be difficult to distinguish from Aspergillus species.
Cultures definitely identifying the fungus are thus required for a diagnosis. Serological antibody testing and skinprick testing may also be helpful, particularly if allergic disease is suspected.
The lung is the most common extracutaneous site of infection, 31 cases of pulmonary infection having been reported.4 7-10 Manifestations of infection have included asymptomatic coin lesions, lung mycetoma, necrotising pneumonia with associated bronchiectasis or abscess formation, transient colonisation, and an infected pleural effusion (one report). Of these, mycetoma was the most common. Of the patients reported, only five neither had underlying lung disease nor were immunosuppressed.4"'0 No cases of allergic bronchopulmonary fungal disease due to P boydii have been reported.
Aspergillus species were the initial fungi to be recognised as causing allergic bronchopulmonary fungal disease when the condition was first described in 1952 and remain the most common fungi implicated in the disease. Mixed allergic bronchopulmonary fungal disease has been described2 but seems uncommon. Our patient had six major and two minor criteria for the diagnosis of allergic bronchopulmonary fungal disease, on the basis of Greenberger's criteria for allergic bronchopulmonary aspergillosis.' The strongly positive precipitin bands and skin test responses to P boydii and the heavy growth of the fungus confirm its likely pathogenicity in this patient. Additionally, the growth of Aspergillus terreus, with a positive skin test response and precipitins, is consistent with mixed allergic bronchopulmonary fungal disease.
Our patient also had positive skin test reactions and precipitins in response to other fungi, a finding common in asthmatic patients, individuals who do not have allergic bronchopulmonary fungal disease. The clinical significance of these reactions is not clear and their presence may in part be due to cross reactivity between common fungi. Cross reactivity between Aspergillus species exists, though in this patient cross reactivity of P boydii with Aspergillus seems unlikely, as shown by immunodiffusion tests using rabbit antisera. This patient's condition supports the concept of "allergic bronchopulmonary fungal disease" as opposed to "allergic bronchopulmonary aspergillosis", as an increasingly wide range of fungi are being shown to cause a syndrome identical to that commonly associated with 
